Jamie A. Mullally, M.D.
Jamie A. Mullally, M.D., is board certified in Internal Medicine, Endocrinology, Diabetes, and Metabolism, and Obesity Medicine. She joined the faculty at NYMC in 2020. Previously, Dr. Mullally was a faculty member at Columbia University College of Physicians and Surgeons where she saw patients in the Division of Endocrinology and Weight Control Center.
In addition to the full spectrum of Endocrine disorders, Dr. Mullally has specialization in Obesity Medicine. She has expertise in providing evidence-based care and effective treatments for patients with metabolic and weight issues to improve their health and quality of life. Dr. Mullally serves on the American Board of Obesity Medicine Maintenance of Certification Committee and on several committees at WMC. She is also accomplished in research areas including obesity and type 2 diabetes and has been an invited speaker at local, regional, and national conferences.
Dr. Mullally also enjoys teaching and was appointed as Associate Program Director of the WMC Fellowship Program in Endocrinology, Diabetes, and Metabolism. She is very involved in educating medical students, Internal Medicine residents, and Endocrinology fellows.
Education
- B.S., Human Biology, Health and Society with Distinction, Cornell University
- M.D. with Distinction in Research and Community Service, University of Rochester
- Residency, Endocrinology, Diabetes, and Metabolism, New York-Presbyterian Hospital/Columbia University Medical Center
- Fellowship, Internal Medicine, New York-Presbyterian Hospital/Weill Cornell Medical Center
Areas of Expertise
- Endocrinology
- Diabetes
- Metabolism
- Obesity Medicine
Honors and Awards
- 2023: Care Champion, WMC; Nominated by a patient for outstanding clinical care
- 2023: Best Fellow Case Report (Mentor for Endocrine Fellow Dr. Aditi Chincholi); WMC 2023 Research Day
- 2017: Outstanding Abstract Award; Endocrine Society 2017 Annual Meeting
- 2010: Alpha Omega Alpha Honor Society; University of Rochester School of Medicine and Dentistry
Publications
- Tetelbaun L, Mullally JA, Frishman WH, et. al. "The First Triple Agonist for Antiobesity: Retatrutide." Cardiology in review, (), (2024) . doi: 10.1097/CRD.0000000000000793
- Krinsky D, Marcucci A, Mullally JA, et. al. "Oral GLP-1 Receptor Agonists for Weight Loss." Cardiology in review, (), (2024) . doi: 10.1097/CRD.0000000000000833
- Chincholi AH, Cooper AR, Mullally JA, et. al. "Treatment of Bisphosphonate-Associated Atypical Femur Fracture With a Combination of Teriparatide and a Novel Surgical Technique." AACE clinical case reports, 10(5), (2024) 170-173. doi: 10.1016/j.aace.2024.05.001
- Jamal Y, Camacho Y, Hanft S, et. al. "A Case of Pituitary Apoplexy and Cavernous Sinus Syndrome during Hemodialysis." Case reports in endocrinology, 2023(), (2023) 3183088. doi: 10.1155/2023/3183088
- Quintas J, Mowatt KB, Mullally JA, et. al. "New-onset persistent hyperglycemia with initiation of brentuximab treatment." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, (), (2023) 10781552231168951. doi: 10.1177/10781552231168951
- Boyle DC, Mullally JA. "Thyrotoxicosis after COVID-19 Infection with a Delay in Graves' Disease Antibody Positivity." Case reports in endocrinology, 2023(), (2023) 8402725. doi: 10.1155/2023/8402725
- D'Ascanio AM, Mullally JA, Frishman WH, et. al. "Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity." Cardiology in review, 32(1), (2024) 83-90. doi: 10.1097/CRD.0000000000000513
Teaching Responsibilities
- Associate Program Director, WMC Fellowship Program in Endocrinology, Diabetes, and Metabolism
- NYMC SYSTEMS 3: Endocrine Block
